The global flow cytometry market size is expected to reach USD 12.29 billion by 2028 according to a new study by Polaris Market Research. The report “Flow Cytometry Market Share, Size, Trends, Industry Analysis Report, By Product (Instruments, Reagents & Consumables, Software, Accessories, Services), By Technology (Cell-based, Bead-based), By Application (Research, Industrial, Clinical), By End-Use, By Region; Segment Forecast, 2021 – 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.
Over the forecast period, the high incidence of chronic diseases, the
launch of technically advanced flow cytometry solutions, and rising R&D
investments in the pharma companies are anticipated to accelerate market
development. Also, the rising incidence of cancer, autoimmune disease
abnormalities, and contagious diseases, such as the COVID-19 outbreak, has boosted
the demand for flow cytometry solutions in clinical and research settings.
According to the American Cancer Society, approximately 1.8 million new
cases of cancer were reported in the U.S. market in 2020. Moreover, as per the
National Cancer Institute (NCI), there were approximately 16.9 million cancer
sufferers in the U.S., as of January 2019.
Get Sample Copy : https://www.polarismarketresearch.com/industry-analysis/flow-cytometry-market/request-for-sample
Growing regulatory approval and the launch of technically advanced flow
cytometry technologies are expected to aid market development of flow
cytometry. Sysmex Corporation, for example, unveiled the XF-1600 cytometers for
laboratories in the U.S., in June 2020.
Besides, Beckman, a Danaher Corporation company, expanded its portfolio
of offerings, in January 2019, with the introduction of its latest ClearLLab
10C System. It is an integrated solution that offers a streamlined workflow
that ensures consistency and reliability in clinical results.
Future market growth opportunities in flow cytometry solutions are
expected to be provided by technological advances that result in increased
accuracy, and cost-effectiveness. Miniaturized high-throughput cytometers are
expected to gain market popularity shortly.
Rapid market advancement in multi-color flow cytometry, which has a wide
range of applications in novel drug formulations, have made it possible to
perform a cell analysis by evaluating several parameters at the same time. Many
contract research companies use these instruments extensively.
Get Special Discount On this Research
Report : https://www.polarismarketresearch.com/industry-analysis/flow-cytometry-market/request-for-discount-pricing
Market participants such as Danaher Corporation, Sysmex Corporation,
Luminex Corporation, Bio-Rad Laboratories, Inc., EMD Millipore, Miltenyi Biotec,
Inc. Becton, Dickinson and Company, Affymetix Inc., Thermo Fischer Scientific,
and Agilent Technologies, Inc. are some of the leading players operating in the
market for flow cytometry.
Polaris Market Research has segmented the flow cytometry market report
based on product, technology, application, end-use, and region:
Flow Cytometry, Product Outlook (Revenue – USD Billion, 2016 – 2028)
- Instruments
- Reagents & Consumables
- Software
- Accessories
- Services
Flow Cytometry, Technology Outlook (Revenue – USD Billion, 2016 – 2028)
- Cell-based
- Bead-based
Flow Cytometry, Application Outlook (Revenue – USD Billion, 2016 – 2028)
- Research
- Industrial
- Clinical
Flow Cytometry, End-Use Outlook (Revenue – USD Billion, 2016 – 2028)
- Commercial Organizations
- Hospitals
- Academic Institutes
- Clinical Testing Labs
Read :
|
|
